Professor Alan Harold Waters MBBS(Hons), PhD, FRCPA, FRACP, FRCPath, FRCP (1934–2009)
Clinical stem cell therapies for severe autoimmune diseases
Two novel null alleles of the KEL gene detected in two Chinese women with the Knull phenotype
Iron deficiency and frequency of HFE C282Y gene mutation in Brazilian blood donors
Retrospective surveillance of HIV prevalence in blood donors can help in the selection of the best social group for blood donation in Mali
Clinical efficacy and safety of Flebogammadif®, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura
Platelet-specific alloantigens and antibodies in Tunisian women after three or more pregnancies
Application of the basophil activation test in the analysis of allergic transfusion reactions
Perioperative patient identification: the patient identification band does not meet the needs of patients in the operating room
Dragging albumin into the 21st century: new albumins that oppose clotting
Transfusion care in the treatment of severe malaria in Uganda: triggers and impact
A situational analysis of blood transfusion in Ghana, West Africa: challenges in the implementation of a national blood transfusion service
Immunoglobulin for patients with primary immune deficiency: an evidence based practice guideline
Prevalence of patient specific HLA antibodies in donors associated with TRALI cases as defined by the Canadian Consensus Conference definition
Cases of platelet transfusion refractoriness (PTR) responding only to apheresis platelets selected for both ABO and HLA compatibility
The eligible blood donor population in Canada
Development of provincial guidelines for home infusion of SCIG
Transfusion-associated circulatory overload (TACO): current leading cause of transfusion-associated fatalities reported to the Québec hemovigilance system
Beyond pandemic: developing a framework for business continuity management in the healthcare environment
CD36 Isoimmunization in a leukemic patient
Modelling the demand for unrelated and alternative allogeneic donors for hematopoietic transplantation due to declining sibling rates in Canada
Medical students' attitudes towards a behaviour-based donor questionnaire
A microfluidic device for genotyping human platelet antigens
Characterization of a novel murine model of immune thrombocytopenia purpura (ITP)
Prevention of RhD recognition and APC presentation by immunocamouflage
In vivo survival of immunocamouflaged RBC in mice: is methoxypoly(ethylene glycol) immunogenic?
West Nile viral load and genotype of viruses in Canadian blood donors during the 2006 and 2007 West Nile seasons
Protein marker for platelet storage lesion by functional proteomics: potential application to predict platelet transfusion outcome
Autologous blood donation in Canada
Stem cell couriers - the Canadian way
Comprehensive assessment of blood transfusion rates between patient services at Capital District Health Authority, Nova Scotia
Comprehensive assessment of blood transfusion rates between hospital sites in Capital District Health Authority, Nova Scotia
Design of and preliminary results from a clinical audit on the use of blood and blood products at Korle-Bu Teaching Hospital (KBTH) in Ghana, West Africa
From crystal ball to data: review of blood order guidelines (BOG) for adult elective surgery
One year audit of transfusion support in bone marrow transplant patients at The Ottawa Hospital
Ontario provincial plasma audit
The use of immunoglobulin for solid organ transplantation: an evidence based practice guideline
Knowledge infusion for transfusion
The implementation of a knowledge transfer strategy to improve blood verification practice at the bedside
Efficient use of web-based tools to stay current with the literature
OCTAPLEX® for the urgent reversal of warfarin: a single institution audit
Blood production interventions and their effect on transfusion-related acute lung injury (TRALI) cases in Canada
Canadian blood services integrity management as a result of the federal hepatitis C compensation program
Core values at CBS and within the LBTB department
Traceback case outcomes vs year of transfusion
A dedicated transfusion medicine rotation for clinical pathology and hematology residents: the UBC experience
Age of blood accepted into inventory within a region participating in blood redistribution
Impact of buffy coat method on usable platelet shelf life and outdating rates
IVIG associated hemolysis: The Sherbrooke experience
A case of severe hemolysis secondary to passive anti-A after administration of intravenous immune globulin
Two cases of fatal hyperhemolysis syndrome following red blood cell transfusion
Maintenance of coagulation factors in thawed plasma over 5 days
Retrospective review of antibodies identified in delayed transfusion reactions at London hospitals 2003-2008
Validation study: use of expired panel cells in antibody investigation
The knowledge transfer of complex antibody investigations is a concern to technical supervisors and transfusion service managers in British Columbia
Anti-SARA: an example of a low prevalence antibody causing severe hemolytic disease of the fetus and newborn
Post implementation monitoring study of the Olympus PK system Rh blood grouping reagents
DAT positive donor deferral management strategy based on a four year retrospective study
Quality improvement (QI) initiative to determine the cause of previously unidentified anti-D in prenatal patients
A quality improvement initiative to decrease platelet wastage-the Royal Victoria Hospital experience
Platelet Ordering: A Random Walk with Ponce de León
A Canadian hospital survey of practices associated with ABO incompatible platelet transfusions
Stewards of the blood supply-crossmatch criteria for rural elective orthopedics
HIT EIA assay: one centre experience
TRALI secondary to group O whole blood emergency transfusion
Platelet Compatibility pre and Post Buffy Coat AT Kingston General Hospital (KGH)
ABO-identical vs. non-identical platelet transfusion. A systematic review
Transfusion surveillance: safety of blood components produced by the buffy coat method
Survey of provincial transfusion services: blood inventory management and contingency planning
Coagulation factor concentrate redistribution in British Columbia
Moving blood in rural Northern Ontario
Developing a provincial online competency assessment tool for transfusion medicine (tm) technologists
Using a provincial toolkit to develop hospital specific contingency plans
Centralized screening of IVIG adult rheumatology requests in British Columbia
A follow-up study on canadian blood donors testing positive for hepatitis B anti-core antibody (ANTI-HBc)
Preventing transfusion transmitted Chagas' disease (Trypanosoma cruzi) and follow-up of donors identified through blood donor screening
Reducing the risk of transfusion-transmitted Babesiosis
The effect of allogeneic red blood cell transfusion on circulating vascular progenitor cells in critically ill patients
Some Platelet-Like Particles Produced In Ex Vivo Cultures Share Morphological and Functional Properties With Normal Platelets
Monomeric IVIG are as efficient as dimer-enriched IVIG for prevention of thrombo-cytopenia in mice
Virus-induced plasma coagulation involves factors VIII and XII
Pax5 overexpression induces multiple myeloma cell death
Validation of the Bact/ALERT® 3D system for implementation of in-house sterility testing at Canadian Blood Services
Prevention of microbial growth in platelets by iron chelators
Evaluation of the effect of Alaris Smart Pump systems on donor platelet function
Automated cryopreservation of red blood cells using Cryo Bio System
Preliminary evaluation of the Haemonetics ACP 215 closed-system cell washer
Comparison of Drabkin's and Harboe methods for % hemolysis determination in packed red blood cell units
Percent hemolysis in Canadian Blood Services red blood cell products
CBS quality monitoring program: comparison of buffy coat and PRP blood components-benchmark for prospective testing
Low concentrations of bradykinin in platelet concentrates collected by apheresis
Persistence of high levels of bradykinin in leukoreduced red cell concentrates during storage
The case of the orange cryoprecipitate
Comparison of frozen plasma produced by the buffy coat method with or without leukofiltration